Delivery Order SPE2DR25D7061-SPE2DR26F7WPC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in 200 ml quantities, with a ceiling value of $1,048.32. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, awarded on September 3, 2025. The award carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,959.86. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.40 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in a 200 ml volume. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, completed on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count) on October 27, 2025, with a ceiling value of $2,117.02. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,322.67, with a completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,279.00 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of VIMPAT 10 mg/mL solution in 200mL quantities. This is a firm fixed price, non-set-aside contract with a completion date of June 6, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,689.20 to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count supply). This competitive, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, under firm fixed-price terms. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 100 mg tablets (60-count units) valued at $2,048.51. This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency has awarded a delivery order valued at $1,221.44 to AmerisourceBergen Drug Corp for VIMPAT 150 mg tablets (60-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on October 20, 2025, and scheduled for completion by October 21, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is a controlled anticonvulsant medication used in...
- SPE2DR25D7061Indefinite Delivery Contract
- SPE2DR25D7061-SPE2DR26F7WPCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,341.90 to AmerisourceBergen Drug Corp for the supply of VIMPAT 200 mg/20 mL vials. This competitive, non-set-aside contract was executed on November 17, 2025, with an ultimate completion date of November 18, 2025, and represents a firm fixed-price transaction. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a child contract under the comprehensive SPE2DX vehicle, this award exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier to the Defense Logistics Agency's Medical Supply Chain. VIMPAT (lacosamide) is a prescription antiepileptic medication used for seizure management, reflecting the broad therapeutic scope of products AmerisourceBergen provides to support military healthcare programs. The company's position as a major pharmaceutical distributor and its demonstrated capability to fulfill federal procurement requirements through open competition have established it as a key vendor for Defense Health Agency and other government healthcare systems requiring specialized medical commodities and brand-name pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/17/25 |